Aurora Cannabis Inc. (ACB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

It was a big day for Canadian cannabis stock Aurora Cannabis (TSE:ACB), as it posted its earnings report with a hefty ...

Aurora Cannabis Inc (TSX:ACB) is set to release its Q3 2025 earnings on Feb 5, 2025. The consensus estimate for Q3 2025 ...

If the pot stock trade is done, someone forget to tell Aurora Cannabis, which is soaring on third quarter results.

Aurora Cannabis posted Q3 FY25 net revenue of CA$88.2 million, driven by medical cannabis and plant propagation growth, with ...

Aurora says net revenue for the three months ended Dec. 31, 2024 topped $88.1 million, up 37 per cent year-over-year. The ...

ACB stock is trading at just 1x forward sales, presenting a buying opportunity, especially on dips, as the company continues to show financial improvement. Looking for more investing ideas like ...